Carmen A. Puliafito
About
In The Last Decade
Carmen A. Puliafito
149 papers receiving 22.3k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Ophthalmology 15.4k
- Radiology, Nuclear Medicine and Imaging 12.7k
- Biomedical Engineering 9.5k
- Biophysics 2.1k
- Molecular Biology 1.8k
Countries citing papers authored by Carmen A. Puliafito
This map shows the geographic impact of Carmen A. Puliafito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen A. Puliafito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen A. Puliafito more than expected).
Fields of papers citing papers by Carmen A. Puliafito
This network shows the impact of papers produced by Carmen A. Puliafito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen A. Puliafito. The network helps show where Carmen A. Puliafito may publish in the future.
Co-authorship network of co-authors of Carmen A. Puliafito
This figure shows the co-authorship network connecting the top 25 collaborators of Carmen A. Puliafito. A scholar is included among the top collaborators of Carmen A. Puliafito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen A. Puliafito. Carmen A. Puliafito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | OCT Angiography (OCTA) of Diabetic Retinopathy | 3 |
| 2 | Pharmacogenomics Of Steroid Response In The Eye | 1 |
| 3 | 26 | |
| 4 | Macular Thickness Measurements in Normal Eyes Using Spectral-Domain Optical Coherence Tomography | 13 |
| 5 | An OCT-Guided Variable-Dosing Regimen With Ranibizumab (Lucentis) in Neovascular AMD: Two Year Results of the PrONTO Study | 2 |
| 6 | Characteristics of Patients Losing Vision at Year 1 of the PrONTO Study | 1 |
| 7 | Quantifying Retinal Layer Thickness Changes in Eyes With Diabetic Diffuse Macular Edema Using Optical Coherence Tomography | 1 |
| 8 | 14 | |
| 9 | 12 | |
| 10 | 50 | |
| 11 | Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration (SANA) Study: Visual Acuity Outcomes | 0 |
| 12 | 3–D OCT Maps of Retinal Pathologies | 1 |
| 13 | Comparing total macular volume changes measured by Optical Coherence Tomography with retinal lesion volume estimated by active contours. | 15 |
| 14 | Optical Coherence Tomography of age-related macular degeneration and choroidal neovascularization | 66 |
| 15 | 119 | |
| 16 | 162 | |
| 17 | 47 | |
| 18 | 10 | |
| 19 | Neodymium yttrium aluminum garnet laser surgery on experimental vitreous membranes | 46 |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.